Skip to main content
SpringerLink
Log in
Book cover

GI Surgery Annual pp 117–135Cite as

Controversies in Surgery for Pancreatic Cancer

  • Chapter
  • First Online:

  • 605 Accesses

Part of the book series: GI Surgery Annual ((GISA,volume 23))

Abstract

Pancreatic cancer continues to be a life-threatening disease with poor long term outcomes despite various treatments. Progress has been slow, although results of surgery have improved, and mortality rates have fallen. Surgery is still the modality with the highest potential to cure pancreatic cancer. We examine some of the key issues relating to the treatment of pancreatic cancer, largely to the description of issues related to pancreatic head cancer.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

    Article  PubMed  Google Scholar 

  2. Gnerlich JL, Luka SR, Deshpande AD, Dubray BJ, Weir JS, Carpenter DH, et al. Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma. Arch Surg. 2012;147:753–60.

    Article  PubMed  Google Scholar 

  3. Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006;10:511–8.

    Article  PubMed  Google Scholar 

  4. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–10.

    Article  CAS  PubMed  Google Scholar 

  5. Smeenk HG, van Eijck CHJ, Hop WC, Erdmann J, Tran KCK, Debois M, et al. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg. 2007;246:734–40.

    Article  PubMed  Google Scholar 

  6. Van Laethem J-L, Hammel P, Mornex F, Azria D, Van Tienhoven G, Vergauwe P, et al. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized trial. J Clin Oncol. 2010;28:4450–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hammel P, Huguet F, van Laethem J-L, Goldstein D, Glimelius B, Artru P, et al. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: The LAP07 randomized clinical trial. JAMA. 2016;315:1844–53.

    Article  CAS  PubMed  Google Scholar 

  8. Andriulli A, Festa V, Botteri E, Valvano MR, Koch M, Bassi C, et al. Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies. Ann Surg Oncol. 2012;19:1644–62.

    Article  PubMed  Google Scholar 

  9. Gillen S, Schuster T, Meyer Zum Buschenfelde C, Friess H, Kleeff J. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010;7:e1000267.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kanda M, Fujii T, Nagai S, Kodera Y, Kanzaki A, Sahin TT, et al. Pattern of lymph node metastasis spread in pancreatic cancer. Pancreas. 2011;40:951–5.

    Article  PubMed  Google Scholar 

  11. Adham M, Jaeck D, Le Borgne J, Oussoultzouglou E, Chenard-Neu M-P, Mosnier J-F, et al. Long-term survival (5–20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions. Pancreas. 2008;37:352–7.

    Article  PubMed  Google Scholar 

  12. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007;246:52–60.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Menon KV, Gomez D, Smith AM, Anthoney A, Verbeke CS. Impact of margin status on survival following pancreatoduodenectomy for cancer: The Leeds Pathology Protocol (LEEPP. HPB (Oxford). 2009;11:18–24.

    Article  Google Scholar 

  14. Gaedcke J, Gunawan B, Grade M, Szoke R, Liersch T, Becker H, et al. The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbecks Arch Surg. 2010;395:451–8.

    Article  CAS  PubMed  Google Scholar 

  15. Gockel I, Domeyer M, Wolloscheck T, Konerding MA, Junginger T. Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space. World J Surg Oncol. 2007;5:44.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Popescu I, Dumitrascu T. Total meso-pancreas excision: key point of resection in pancreatic head adenocarcinoma. Hepatogastroenterology. 2011;58:202–7.

    PubMed  Google Scholar 

  17. Kawabata Y, Tanaka T, Nishi T, Monma H, Yano S, Tajima Y. Appraisal of a total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma. Eur J Surg Oncol. 2012;38:574–9.

    Article  CAS  PubMed  Google Scholar 

  18. Peparini N, Caronna R, Chirletti P. The ‘meso’ of the rectum and the ‘meso’ of the pancreas: similar terms but distinct concepts in surgical oncology. Hepatobiliary Pancreat Dis Int. 2015;14:548–51.

    Article  PubMed  Google Scholar 

  19. Chowdappa R, Challa VR. Mesopancreas in pancreatic cancer: where do we stand—review of literature. Indian J Surg Oncol. 2015;6:69–74.

    Article  PubMed  Google Scholar 

  20. Dumitrascu T, Popescu I. Total mesopancreas excision in pancreatic head adenocarcinoma: the same impact as total mesorectal excision in rectal carcinoma? Comment on article ‘surgical technique and results of total mesopancreas excision in pancreatic tumours’ by Adham M and Singhirunnusorn J, Eur J Surg Oncol, 2012. Eur J Surg Oncol 2012;38:725; author reply 726.

    Google Scholar 

  21. Welsch T, Bork U, Distler M, Weitz J. Top-down approach to the superior mesenteric artery and the mesopancreas during pancreatoduodenectomy for pancreatic cancer. J Surg Oncol. 2016;113:668–71.

    Article  PubMed  Google Scholar 

  22. Adham M, Singhirunnusorn J. Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors. Eur J Surg Oncol. 2012;38:340–5.

    Article  CAS  PubMed  Google Scholar 

  23. Wellner UF, Krauss T, Csanadi A, Lapshyn H, Bolm L, Timme S, et al. Mesopancreatic stromal clearance defines curative resection of pancreatic head cancer and can be predicted preoperatively by radiologic parameters: a retrospective study. Medicine (Baltimore). 2016;95:e2529.

    Article  Google Scholar 

  24. Nitschke P, Volk A, Welsch T, Hackl J, Reissfelder C, Rahbari M, et al. Impact of intraoperative re-resection to achieve R0 status on survival in patients with pancreatic cancer: a single-center experience with 483 patients. Ann Surg 2016; published online June 8.

    Google Scholar 

  25. Takaori K, Bassi C, Biankin A, Brunner TB, Cataldo I, Campbell F, et al. International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer. Pancreatology. 2016;16:14–27.

    Article  PubMed  Google Scholar 

  26. Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA. 2010;304:1073–81.

    Article  CAS  PubMed  Google Scholar 

  27. Evans DB, Farnell MB, Lillemoe KD, Vollmer CJ, Strasberg SM, Schulick RD. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009;16:1736–44.

    Article  PubMed  Google Scholar 

  28. Gill AJ, Johns AL, Eckstein R, Samra JS, Kaufman A, Chang DK, et al. Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology 2009;41:161–7.

    Google Scholar 

  29. Campbell F, Smith RA, Whelan P, Sutton R, Raraty M, Neoptolemos JP, et al. Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin. Histopathology. 2009;55:277–83.

    Article  PubMed  Google Scholar 

  30. Delpero JR, Bachellier P, Regenet N, Le Treut YP, Paye F, Carrere N, et al. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. HPB (Oxford). 2014;16:20–33.

    Article  Google Scholar 

  31. Chang DK, Johns AL, Merrett ND, Gill AJ, Colvin EK, Scarlett CJ, et al. Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol. 2009;27:2855–62.

    Article  PubMed  Google Scholar 

  32. Chandrasegaram MD, Goldstein D, Simes J, Gebski V, Kench JG, Gill AJ, et al. Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. Br J Surg. 2015;102:1459–72.

    Article  CAS  PubMed  Google Scholar 

  33. Tseng JF, Pisters PWT, Lee JE, Wang H, Gomez HF, Sun CC, et al. The learning curve in pancreatic surgery. Surgery. 2007;141:694–701.

    Article  PubMed  Google Scholar 

  34. Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008;15:1651–60.

    Article  PubMed  Google Scholar 

  35. Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. Br J Surg. 2006;93:1232–7.

    Article  CAS  PubMed  Google Scholar 

  36. Rau BM, Moritz K, Schuschan S, Alsfasser G, Prall F, Klar E. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery. 2012;152:S103–11.

    Article  PubMed  Google Scholar 

  37. Maksymov V, Hogan M, Khalifa MA. An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment. HPB (Oxford). 2013;15:218–23.

    Article  Google Scholar 

  38. Gebauer F, Tachezy M, Vashist YK, Marx AH, Yekebas E, Izbicki JR, et al. Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic? World J Surg. 2015;39:493–9.

    Article  PubMed  Google Scholar 

  39. Fuhrman GM, Leach SD, Staley CA, Cusack JC, Charnsangavej C, Cleary KR, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg. 1996;223:154–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Ishikawa O, Ohigashi H, Imaoka S, Furukawa H, Sasaki Y, Fujita M, et al. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg. 1992;215:231–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Nakao A, Kanzaki A, Fujii T, Kodera Y, Yamada S, Sugimoto H, et al. Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg. 2012;255:103–8.

    Article  PubMed  Google Scholar 

  42. Pilgrim CHC, Tsai S, Tolat P, Patel P, Rilling W, Evans DB, et al. Optimal management of the splenic vein at the time of venous resection for pancreatic cancer: Importance of the inferior mesenteric vein. J Gastrointest Surg. 2014;18:917–21.

    Article  PubMed  Google Scholar 

  43. Smoot RL, Christein JD, Farnell MB. An innovative option for venous reconstruction after pancreaticoduodenectomy: the left renal vein. J Gastrointest Surg. 2007;11:425–31.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Dokmak S. Pancreaticoduodenectomy with reconstruction of the mesentericoportal vein by the parietal peritoneum: ‘Safi Dokmak Vascular Graft’. Ann Surg Oncol 2015;22 Suppl 3:S343–S344.

    Google Scholar 

  45. Dokmak S, Aussilhou B, Sauvanet A, Nagarajan G, Farges O, Belghiti J. Parietal peritoneum as an autologous substitute for venous reconstruction in hepatopancreatobiliary surgery. Ann Surg. 2015;262:366–71.

    Article  PubMed  Google Scholar 

  46. Smoot RL, Christein JD, Farnell MB. Durability of portal venous reconstruction following resection during pancreaticoduodenectomy. J Gastrointest Surg. 2006;10:1371–5.

    Article  PubMed  Google Scholar 

  47. Kim PTW, Wei AC, Atenafu EG, Cavallucci D, Cleary SP, Moulton C-A, et al. Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma. Br J Surg. 2013;100:1349–56.

    Article  CAS  PubMed  Google Scholar 

  48. Barreto SG, Windsor JA. Justifying vein resection with pancreatoduodenectomy. Lancet Oncol. 2016;17:e118–24.

    Article  PubMed  Google Scholar 

  49. Yu XZ, Li J, DL F, Di Y, Yang F, Hao SJ, et al. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis. Eur J Surg Oncol. 2014;40:371–8.

    Article  CAS  PubMed  Google Scholar 

  50. Turrini O, Ewald J, Barbier L, Mokart D, Blache JL, Delpero JR. Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma? Ann Surg. 2013;257:726–30.

    Article  PubMed  Google Scholar 

  51. Fortner JG, Kim DK, Cubilla A, Turnbull A, Pahnke LD, Shils ME. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg. 1977;186:42–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Buchler MW, et al. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg. 2011;254:882–93.

    Article  PubMed  Google Scholar 

  53. Hicks CW, Burkhart RA, Weiss MJ, Wolfgang CL, Cameron AM, Pawlik TM. Management of type 9 hepatic arterial anatomy at the time of pancreaticoduodenectomy: considerations for preservation and reconstruction of a completely replaced common hepatic artery. J Gastrointest Surg. 2016;20:1400–4.

    Article  PubMed  Google Scholar 

  54. Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R. Extended resections of ductal pancreatic cancer—impact on operative risk and prognosis. Oncology. 1996;53:47–53.

    Article  CAS  PubMed  Google Scholar 

  55. Hartwig W, Hackert T, Hinz U, Hassenpflug M, Strobel O, Buchler MW, et al. Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg. 2009;250:81–7.

    Article  PubMed  Google Scholar 

  56. Burdelski CM, Reeh M, Bogoevski D, Gebauer F, Tachezy M, Vashist YK, et al. Multivisceral resections in pancreatic cancer: identification of risk factors. World J Surg. 2011;35:2756–63.

    Article  PubMed  Google Scholar 

  57. Hartwig W, Vollmer CM, Fingerhut A, Yeo CJ, Neoptolemos JP, Adham M, et al. Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS). Surgery. 2014;156:1–14.

    Article  PubMed  Google Scholar 

  58. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study group. Ann Surg. 1998;228:508–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg. 1999;229:613–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Nimura Y, Nagino M, Takao S, Takada T, Miyazaki K, Kawarada Y, et al. Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci. 2012;19:230–41.

    Article  PubMed  Google Scholar 

  61. Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005;138:618–28.

    Article  PubMed  Google Scholar 

  62. Pedrazzoli S, Beger HG, Obertop H, Andren-Sandberg A, Fernandez-Cruz L, Henne-Bruns D, et al. A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg. 1999;16:337–45.

    Article  CAS  PubMed  Google Scholar 

  63. Tol JAMG, Gouma DJ, Bassi C, Dervenis C, Montorsi M, Adham M, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS. Surgery. 2014;156:591–600.

    Article  PubMed  Google Scholar 

  64. Michalski CW, Kleeff J, Wente MN, Diener MK, Buchler MW, Friess H. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg. 2007;94:265–73.

    Article  CAS  PubMed  Google Scholar 

  65. Pedrazzoli S, Michelassi F. Extent of lymphadenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas. J Gastrointest Surg. 2000;4:229–30.

    Article  CAS  PubMed  Google Scholar 

  66. Pedrazzoli S. Extent of lymphadenectomy to associate with pancreaticoduodenectomy in patients with pancreatic head cancer for better tumor staging. Cancer Treat Rev. 2015;41:577–87.

    Article  PubMed  Google Scholar 

  67. Malleo G, Maggino L, Capelli P, Gulino F, Segattini S, Scarpa A, et al. Reappraisal of nodal staging and study of lymph node station involvement in pancreaticoduodenectomy with the standard International Study Group of Pancreatic Surgery definition of lymphadenectomy for cancer. J Am Coll Surg 2015;221:367–379.e4.

    Google Scholar 

  68. Peparini N. Para-Aortic dissection in pancreaticoduodenectomy with mesopancreas excision for pancreatic head carcinoma: Not only an N-staging matter. J Gastrointest Surg. 2016;20:1080–1.

    Article  PubMed  Google Scholar 

  69. Paiella S, Malleo G, Maggino L, Bassi C, Salvia R, Butturini G. Pancreatectomy with para-aortic lymph node dissection for pancreatic head adenocarcinoma: pattern of nodal metastasis spread and analysis of prognostic factors. J Gastrointest Surg. 2015;19:1610–20.

    Article  PubMed  Google Scholar 

  70. Gagner M, Pomp A. Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc. 1994;8:408–10.

    Article  CAS  PubMed  Google Scholar 

  71. Mesleh MG, Stauffer JA, Asbun HJ. Minimally invasive surgical techniques for pancreatic cancer: ready for prime time? J Hepatobiliary Pancreat Sci. 2013;20:578–82.

    Article  PubMed  Google Scholar 

  72. Wang M, Meng L, Cai Y, Li Y, Wang X, Zhang Z, et al. Learning curve for laparoscopic pancreaticoduodenectomy: a CUSUM analysis. J Gastrointest Surg. 2016;20:924–35.

    Article  PubMed  Google Scholar 

  73. Gooiker GA, van Gijn W, Wouters MWJM, Post PN, van de Velde CJH, Tollenaar RAEM. Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br J Surg. 2011;98:485–94.

    Article  CAS  PubMed  Google Scholar 

  74. Cho A, Yamamoto H, Nagata M, Takiguchi N, Shimada H, Kainuma O, et al. Comparison of laparoscopy-assisted and open pylorus-preserving pancreaticoduodenectomy for periampullary disease. Am J Surg. 2009;198:445–9.

    Article  PubMed  Google Scholar 

  75. Palanivelu C, Jani K, Senthilnathan P, Parthasarathi R, Rajapandian S, Madhankumar MV. Laparoscopic pancreaticoduodenectomy: technique and outcomes. J Am Coll Surg. 2007;205:222–30.

    Article  PubMed  Google Scholar 

  76. Palanisamy S, Deuri B, Naidu SB, Vaiyapurigoundar Palanisamy N, Natesan AV, Palanivelu PR, et al. Major venous resection and reconstruction using a minimally invasive approach during laparoscopic pancreaticoduodenectomy: one step forward. Asian J Endosc Surg. 2015;8:468–72.

    Article  PubMed  Google Scholar 

  77. Doula C, Kostakis ID, Damaskos C, Machairas N, Vardakostas DV, Feretis T, et al. Comparison between minimally invasive and open pancreaticoduodenectomy: a systematic review. Surg Laparosc Endosc Percutan Tech. 2016;26:6–16.

    Article  PubMed  Google Scholar 

  78. Correa-Gallego C, Dinkelspiel HE, Sulimanoff I, Fisher S, Vinuela EF, Kingham TP, et al. Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis. J Am Coll Surg. 2014;218:129–39.

    Article  PubMed  Google Scholar 

  79. Kendrick ML, Sclabas GM. Major venous resection during total laparoscopic pancreaticoduodenectomy. HPB (Oxford). 2011;13:454–8.

    Article  Google Scholar 

  80. Dokmak S, Fteriche FS, Aussilhou B, Bensafta Y, Levy P, Ruszniewski P, et al. Laparoscopic pancreaticoduodenectomy should not be routine for resection of periampullary tumors. J Am Coll Surg. 2015;220:831–8.

    Article  PubMed  Google Scholar 

  81. Boggi U, Signori S, De Lio N, Perrone VG, Vistoli F, Belluomini M, et al. Feasibility of robotic pancreaticoduodenectomy. Br J Surg. 2013;100:917–25.

    Article  CAS  PubMed  Google Scholar 

  82. Cirocchi R, Partelli S, Trastulli S, Coratti A, Parisi A, Falconi MA. Systematic review on robotic pancreaticoduodenectomy. Surg Oncol. 2013;22:238–46.

    Article  PubMed  Google Scholar 

  83. Zeh HJ, Zureikat AH, Secrest A, Dauoudi M, Bartlett D, Moser AJ. Outcomes after robot-assisted pancreaticoduodenectomy for periampullary lesions. Ann Surg Oncol. 2012;19:864–70.

    Article  PubMed  Google Scholar 

  84. Bao P, Potter D, Eisenberg DP, Lenzner D, Zeh HJ, Lee Iii KK, et al. Validation of a prediction rule to maximize curative (R0) resection of early-stage pancreatic adenocarcinoma. HPB (Oxford). 2009;11:606–11.

    Article  Google Scholar 

  85. National comprehensive cancer network practice guidelines in oncology for pancreatic adenocarcinoma. November 2008. Available at www.nccn.org . Accessed on 15 Jun 2016.

  86. Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009;16:1727–33.

    Article  PubMed  Google Scholar 

  87. Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13:1035–46.

    Article  PubMed  Google Scholar 

  88. Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, et al. Borderline resectable pancreatic cancer: The importance of this emerging stage of disease. J Am Coll Surg 2008;206:833–846; discussion 846–8.

    Google Scholar 

  89. Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, et al. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. J Gastrointest Surg 2014;18:269–278; discussion 278.

    Google Scholar 

  90. Bilimoria KY, Talamonti MS, Sener SF, Bilimoria MM, Stewart AK, Winchester DP, et al. Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer. J Am Coll Surg. 2008;207:510–9.

    Article  PubMed  Google Scholar 

  91. Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al. European Study Group for Pancreatic Cancer. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234:758–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 2006;10:1199–1210; discussion 1210–1.

    Google Scholar 

  93. Apte MV, Park S, Phillips PA, Santucci N, Goldstein D, Kumar RK, et al. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas. 2004;29:179–87.

    Article  CAS  PubMed  Google Scholar 

  94. Allema JH, Reinders ME, van Gulik TM, van Leeuwen DJ, de Wit LT, Verbeek PC, et al. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg. 1994;81:1642–6.

    Article  CAS  PubMed  Google Scholar 

  95. Seufferlein T, Bachet JB, Van Cutsem E, Rougier P; ESMO Guidelines Working Group. Pancreatic adenocarcinoma: ESMO-ESDO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23 Suppl 7:vii33–40.

    Google Scholar 

  96. Pessaux P, Varma D, Arnaud JP. Pancreaticoduodenectomy: Superior mesenteric artery first approach. J Gastrointest Surg. 2006;10:607–11.

    Article  PubMed  Google Scholar 

  97. Makino I, Kitagawa H, Ohta T, Nakagawara H, Tajima H, Ohnishi I, et al. Nerve plexus invasion in pancreatic cancer: Spread patterns on histopathologic and embryological analyses. Pancreas. 2008;37:358–65.

    Article  PubMed  Google Scholar 

  98. Hirota M, Kanemitsu K, Takamori H, Chikamoto A, Tanaka H, Sugita H, et al. Pancreatoduodenectomy using a no-touch isolation technique. Am J Surg. 2010;199:e65–8.

    Article  PubMed  Google Scholar 

  99. Weitz J, Rahbari N, Koch M, Büchler MW. The “artery first” approach for resection of pancreatic head cancer. J Am Coll Surg. 2010;210:e1–4.

    Article  PubMed  Google Scholar 

  100. Hackert T, Werner J, Weitz J, Schmidt J, Büchler MW. Uncinate process first—a novel approach for pancreatic head resection. Langenbecks Arch Surg. 2010;395:1161–4.

    Article  PubMed  Google Scholar 

  101. Kurosaki I, Minagawa M, Takano K, Takizawa K, Hatakeyama K. Left posterior approach to the superior mesenteric vascular pedicle in pancreaticoduodenectomy for cancer of the pancreatic head. JOP. 2011;12:220–9.

    PubMed  Google Scholar 

  102. Pavlidis TE, Pavlidis ET, Sakantamis AK. Current opinion on lymphadenectomy in pancreatic cancer surgery. Hepatobiliary Pancreat Dis Int. 2011;10:21–5.

    Article  PubMed  Google Scholar 

  103. Glanemann M, Shi B, Liang F, Sun XG, Bahra M, Jacob D, et al. Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery? World J Surg Oncol. 2008;6:123.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Wilkowski R, Wolf M, Heinemann V. Primary advanced unresectable pancreatic cancer. Recent Results Cancer Res. 2008;177:79–93.

    Article  CAS  PubMed  Google Scholar 

  105. Kitagawa H, Ohta T, Makino I, Tani T, Tajima H, Nakagawara H, et al. Carcinomas of the ventral and dorsal pancreas exhibit different patterns of lymphatic spread. Front Biosci. 2008;13:2728–35.

    Article  CAS  PubMed  Google Scholar 

  106. Kostov D. Lymphadenectomy in pancreatic cancer surgery. In: Recent advances in pancreatic cancer. Available at www.avidscience.com/book/recent-advances-in-pancreatic-cancer/ . Accessed on 15 Jul 2016.

  107. Kontis E, Prassas E, Srinivasan P, Prachalias A. Extended lymphadenectomy and mesopancreas excision during pancreatoduodenectomy for cancer: is it worth it? Review of current evidence. J Pancreas. 2016;17:149–58.

    Google Scholar 

  108. Pedrrazzoli S, Pasqua C, Sperti C. Extent of lymphadenectomy in the resection of pancreatic cancer. Analysis of the existing evidence. Ann Acad Med Bialoostacensis. 2005;50:85–90.

    Google Scholar 

  109. Cady B. Fundamentals of contemporary surgical oncology: Biologic principles and the threshold concept govern treatment and outcomes. J Am Coll Surg. 2001;192:777–92.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Gastroenterology and Liver Transplantation, Lakeshore Hospital, Kochi, Kerala, India

    H. Ramesh, Jacob Mathew, John Mathew Manipadam & Saurabh Galodha

Authors
  1. H. Ramesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacob Mathew
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Mathew Manipadam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Saurabh Galodha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Ramesh .

Editor information

Editors and Affiliations

  1. Department of GI Surgery and Liver Transplantation, All India Institue of Medical Sciences , New Delhi, Delhi, India

    Peush Sahni

  2. Department of GI Surgery and Liver Transplantation, All India Institute of Medical Sciences , New Delhi, Delhi, India

    Sujoy Pal

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Indian Association of Surgical Gastroenterology

About this chapter

Cite this chapter

Ramesh, H., Mathew, J., Manipadam, J.M., Galodha, S. (2017). Controversies in Surgery for Pancreatic Cancer. In: Sahni, P., Pal, S. (eds) GI Surgery Annual. GI Surgery Annual, vol 23. Springer, Singapore. https://doi.org/10.1007/978-981-10-2678-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-2678-2_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-2677-5

  • Online ISBN: 978-981-10-2678-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation